NIOX Group PLC (NIOX)
Industry Medical Devices
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
67.20p
Buy
69.20p
1.00p (+1.48%)
Prices updated at 12 Dec 2025, 16:35 GMT
| Prices minimum 15 mins delay
Prices in GBX
Circassia Pharmaceuticals PLC is a biotechnology company. It is engaged in the development and commercialization of range of therapies for asthma and chronic obstructive pulmonary disease.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 72.25 |
| 2023 | 72.01 |
| 2022 | 70.93 |
| 2021 | 68.10 |
| 2020 | 68.20 |
| 2019 | 73.70 |
| 2018 | 81.57 |
| 2017 | 78.40 |
| 2016 | 65.37 |
| 2015 | 60.19 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 6.46 |
| 2024 | 7.29 |
| 2023 | 8.63 |
| 2022 | 5.75 |
| 2021 | 6.27 |
| 2020 | 1.85 |
| 2019 | 1.45 |
| 2018 | 2.84 |
| 2017 | 10.14 |
| 2016 | 12.90 |
| 2015 | - |
Price/Forward earnings (YTD)
-
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | 4.63 |
| 2023 | 11.26 |
| 2022 | 17.41 |
| 2021 | 3.80 |
| 2020 | -19.15 |
| 2019 | -17.43 |
| 2018 | -33.00 |
| 2017 | -26.91 |
| 2016 | -33.35 |
| 2015 | -14.47 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.15 |
| 2023 | 1.09 |
| 2022 | 1.20 |
| 2021 | 1.29 |
| 2020 | 1.56 |
| 2019 | 2.91 |
| 2018 | 2.44 |
| 2017 | 1.79 |
| 2016 | 1.19 |
| 2015 | 1.20 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
